Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sazani

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|August 20, 2003
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicingPeter Sazani, Ryszard Kole
International Journal of Cancer|November 28, 2008
Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cellsJing Wan, Peter Sazani, Ryszard Kole
Antisense & Nucleic Acid Drug Development|September 5, 2003
Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotidesPeter Sazani, Anna Astriab-Fischer, Ryszard Kole
Current Opinion in Biotechnology|December 3, 2002
Short-term and long-term modulation of gene expression by antisense therapeuticsPeter Sazani, Marla M Vacek, Ryszard Kole
International Journal of Toxicology|January 30, 2010
Safety pharmacology and genotoxicity evaluation of AVI-4658Peter Sazani, Doreen L Weller, Stephen B Shrewsbury
Nucleic Acids Research|November 1, 2002
Temperature-dependent splicing of beta-globin pre-mRNAFederica Gemignani, Peter Sazani, Paul Morcos, et al.
Cardiovascular Research|October 10, 2009
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomersNatee Jearawiriyapaisarn, Hong M Moulton, Peter Sazani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2006
Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in miceJennifer Roberts, Enzo Palma, Peter Sazani, et al.
Cancer Treatment and Research|November 14, 2013
Oligonucleotide therapeutics in cancerJing Wan, John A Bauman, Maria Anna Graziewicz, et al.
Annals of the New York Academy of Sciences|October 3, 2009
Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophyHong M Moulton, Bo Wu, Natee Jearawiriyapaisarn, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|August 20, 2003
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicingPeter Sazani, Ryszard Kole
International Journal of Cancer|November 28, 2008
Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cellsJing Wan, Peter Sazani, Ryszard Kole
Antisense & Nucleic Acid Drug Development|September 5, 2003
Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotidesPeter Sazani, Anna Astriab-Fischer, Ryszard Kole
Current Opinion in Biotechnology|December 3, 2002
Short-term and long-term modulation of gene expression by antisense therapeuticsPeter Sazani, Marla M Vacek, Ryszard Kole
International Journal of Toxicology|January 30, 2010
Safety pharmacology and genotoxicity evaluation of AVI-4658Peter Sazani, Doreen L Weller, Stephen B Shrewsbury
Nucleic Acids Research|November 1, 2002
Temperature-dependent splicing of beta-globin pre-mRNAFederica Gemignani, Peter Sazani, Paul Morcos, et al.
Cardiovascular Research|October 10, 2009
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomersNatee Jearawiriyapaisarn, Hong M Moulton, Peter Sazani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2006
Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in miceJennifer Roberts, Enzo Palma, Peter Sazani, et al.
Cancer Treatment and Research|November 14, 2013
Oligonucleotide therapeutics in cancerJing Wan, John A Bauman, Maria Anna Graziewicz, et al.
Annals of the New York Academy of Sciences|October 3, 2009
Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophyHong M Moulton, Bo Wu, Natee Jearawiriyapaisarn, et al.
Pageof 3